07-16-2018 03:35:09 PM -0700
07-16-2018 10:17:06 AM -0700
07-16-2018 07:10:22 AM -0700
07-15-2018 02:41:03 PM -0700
07-13-2018 10:59:54 AM -0700
It looks like you've previously blocked notifications. If you'd like to receive them, please update your browser permissions.
Desktop Notifications are  | 
Get instant alerts on your desktop.
Turn on desktop notifications?
Remind me later.

Could Re-Purposing Drugs Lead to Victories Against Cancer?

Some of today’s most popular and widely utilized drugs are the serendipitous result of products and therapies that didn’t quite work out as researchers had planned.

Warfarin, for example, a lifesaving anticoagulant used by millions, was initially created in order to kill rats by causing them to bleed internally.  The popular hair-restoration treatment Minoxidil was the surprising result of an anti-hypertensive medication that happened to also increase hair growth. And perhaps one of the most financially rewarding pharmaceutical  accidents of all time, the scientists behind Viagra entered it into clinical trials as a therapy for angina and high blood pressure.

For many years, scientists have also known that some drugs – in addition to their intended purpose – can have anti-cancer side-effects. A staple of nearly every American’s medicine cabinet, Aspirin can reduce the risk of colon cancer. Methylnaltrexone, an opiate antagonist that relieves the peripheral side effects of opiates while preserving analgesia, can increase survival in advanced cancer patients.

In the past five years, researchers have stepped up efforts to find ways to harness existing approved drugs, and repurpose them for treating cancer.  One smart way to think about any drug is by understanding how it works inside a cell; sometimes that mechanism of drug action could suggest it will have a parallel application as an anti-cancer drug. As the costs of bringing an anti-cancer drug to the market can cost in the hundreds of millions of dollars, this approach of repurposing could be a cost-effective way to increase our drug inventory of anti-cancer drugs.

Perhaps one of the most surprising drugs being newly used as a cancer-fighting agent shouldn’t be any surprise at all. Viagra – already having proved itself to be more useful as an erectile dysfunction treatment than as an antihypertensive – has shown significant promise for patients with certain types of solid tumors and brain cancers.

Along with Cialis and Levitra, Viagra works by producing a chemical called nitric oxide – a potent vasodilator that relaxes blood vessels to help increase blood flow. In men with erectile dysfunction, it’s a mechanism that helps increase blood flow to the penis, thereby causing an erection. But in cancer cells, nitric oxide reacts with toxic free radicals to make a super-free radical– which make the cancer cell feel “unwell,” but doesn’t actually kill it.

However, when Viagra is combined with many types of chemotherapy, the synergistic cancer-killing  effect is remarkable. Two drug combinations with Viagra are already actively in use with patients, with promising results. Viagra paired with the seizure medication Depakote and the cancer drug Nexavar, is gaining steam as an encouraging treatment for patients with recurrent brain cancer as part of an on-going phase II clinical trial (trial: NCT01817751).  Likewise, the phase I trial administering Viagra with a cancer drug called Stivarga isnearing completion with multiple patients on trial for over a year (trial: NCT02466802). Viagra has certainly proven to be one of the most versatile, but it’s far from the only drug able to be repurposed for cancer.

Tecfidera is a multiple sclerosis medication able to augment cancer-fighting radiation and chemotherapy in patients with brain cancer (trial: NCT02337426). Like aspirin, the common anti-inflammatory drug Celebrex can be used to prevent colon cancer.